TAKE THIS POLL |
|
|
- Astellas Pharma and XenoPort submit NDA in Japan for PMDA approval 19 Nov 2009 12:57 GMT
... in unlocking one of the centra... A promising new HIV vaccine created at The Wistar Institute has received funding for clinical develo... An international team of researchers, led by Emory ...
- Attacking normal cells slows tumor growth 19 Nov 2009 19:50 GMT
... say they've discovered targeting normal cells in tumors slows the growth of the cancer. Wistar Institute scientists say attacking the normal cells that surround cancer cells within and around a ...
- Wistar researchers show targeting 'normal' cells in tumors slows growth 16 Nov 2009 22:51 GMT
... that could greatly increase the effectiveness of traditional anti-cancer treatments, say researchers at The Wistar Institute. published online November 16, they demonstrate the critical role for fibroblast activation protein (FAP), ...
- Targeting 'Normal' Cells in Tumors Slows Growth 16 Nov 2009 22:52 GMT
... that could greatly increase the effectiveness of traditional anti-cancer treatments, say researchers at The Wistar Institute. published online November 16, they demonstrate the critical role for fibroblast activation protein (FAP), ...
- Targeting "Normal" Cells In Tumors Slows Growth 17 Nov 2009 18:31 GMT
... that could greatly increase the effectiveness of traditional anti-cancer treatments, say researchers at The Wistar Institute. In the published online November 16, they demonstrate the critical role for fibroblast activation ...
1 - 8 of 8
Powered by 
News by PR Newswire
24-7 pressrelease
Emailwire
|